WO2012048165A2
(en)
|
2010-10-06 |
2012-04-12 |
President And Fellows Of Harvard College |
Injectable, pore-forming hydrogels for materials-based cell therapies
|
WO2013185052A1
(en)
*
|
2012-06-08 |
2013-12-12 |
Aduro Biotech |
Compostions and methods for cancer immunotherapy
|
WO2014093936A1
(en)
|
2012-12-13 |
2014-06-19 |
Aduro Biotech, Inc. |
Compositions comprising cyclic purine dinucleotides having defined stereochemistries and methods for their preparation and use
|
CA2895175C
(en)
|
2012-12-19 |
2021-06-01 |
Board Of Regents, The University Of Texas System |
Pharmaceutical targeting of a mammalian cyclic di-nucleotide signaling pathway
|
BR112015027327B1
(en)
|
2013-04-29 |
2022-08-02 |
Rutgers, The State University Of New Jersey |
COMPOUND, CGA MODULATOR, PHARMACEUTICAL COMPOSITION INCLUDING SUCH COMPOUND OR MODULATOR
|
CN105377867B
(en)
|
2013-05-03 |
2019-11-12 |
加利福尼亚大学董事会 |
The cyclic annular dinucleotides of I type interferon induces
|
US9549944B2
(en)
|
2013-05-18 |
2017-01-24 |
Aduro Biotech, Inc. |
Compositions and methods for inhibiting “stimulator of interferon gene”—dependent signalling
|
JP6453855B2
(en)
|
2013-05-18 |
2019-01-16 |
アドゥロ バイオテック,インク. |
Compositions and methods for activating "interferon gene stimulator" dependent signaling
|
JP6400082B2
(en)
*
|
2013-05-18 |
2018-10-03 |
アデュロ バイオテック,インコーポレイテッド |
Compositions and methods for inhibiting "stimulating factor of interferon gene" dependent signaling
|
WO2015017652A1
(en)
|
2013-07-31 |
2015-02-05 |
Memorial Sloan-Kettering Cancer Center |
Sting crystals and modulators
|
US20160287623A1
(en)
*
|
2013-11-19 |
2016-10-06 |
The University Of Chicago |
Use of sting agonist as cancer treatment
|
CN103908468B
(en)
*
|
2014-04-21 |
2017-02-08 |
上海捌加壹医药科技有限公司 |
Application of cyclic dinucleotide cGAMP in preparing anti-tumor medicaments
|
US10682400B2
(en)
|
2014-04-30 |
2020-06-16 |
President And Fellows Of Harvard College |
Combination vaccine devices and methods of killing cancer cells
|
JP6462006B2
(en)
|
2014-06-04 |
2019-01-30 |
グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドGlaxosmithkline Intellectual Property Development Limited |
Cyclic dinucleotides as modulators of STING
|
WO2016079899A1
(en)
*
|
2014-11-20 |
2016-05-26 |
国立研究開発法人医薬基盤・健康・栄養研究所 |
NOVEL Th1-INDUCING ADJUVANT COMPRISING COMBINATION OF DIFFERENT NUCLEIC ACID ADJUVANTS, AND USE OF SAME
|
EP3233882B1
(en)
|
2014-12-16 |
2019-10-30 |
Kayla Therapeutics |
Fluorinated cyclic dinucleotides for cytokine induction
|
GB201501462D0
(en)
|
2015-01-29 |
2015-03-18 |
Glaxosmithkline Ip Dev Ltd |
Novel compounds
|
CA3013713A1
(en)
|
2015-02-11 |
2016-08-18 |
The Johns Hopkins University |
Bacteria over-expressing c-di-amp and therapeutic methods
|
KR20170129802A
(en)
*
|
2015-03-10 |
2017-11-27 |
아두로 바이오테크, 인코포레이티드 |
Compositions and methods for activating "stimulating factors" -dependent signaling of interferon genes
|
US11571462B2
(en)
|
2015-06-03 |
2023-02-07 |
The Medical College Of Wisconsin, Inc. |
Engineered CCL20 locked dimer polypeptide
|
AU2016271292B2
(en)
|
2015-06-03 |
2022-04-14 |
The Medical College Of Wisconsin, Inc. |
An engineered CCL20 locked dimer polypeptide
|
US11453697B1
(en)
|
2015-08-13 |
2022-09-27 |
Merck Sharp & Dohme Llc |
Cyclic di-nucleotide compounds as sting agonists
|
GEP20207182B
(en)
|
2015-08-13 |
2020-11-25 |
Merck Sharp & Dohme |
Cyclic di-nucleotide compounds as sting agonists
|
MA48579A
(en)
|
2015-09-01 |
2020-03-18 |
Agenus Inc |
ANTI-PD1 ANTIBODIES AND METHODS OF USING THEM
|
CN105367617A
(en)
*
|
2015-09-25 |
2016-03-02 |
武汉品生科技有限公司 |
Derivative based on c-di-AMP, tat polypeptide and application of derivative in inhibitor in type I interferon micromolecules
|
AU2016343993A1
(en)
|
2015-10-28 |
2018-05-10 |
Aduro Biotech, Inc. |
Compositions and methods for activating "stimulator of interferon gene"-dependent signalling
|
CN106539813B
(en)
*
|
2015-11-30 |
2019-12-03 |
杭州星鳌生物科技有限公司 |
Application of interferon-stimulated gene (STING) activator in anti-inflammatory
|
MA52157A
(en)
|
2015-12-03 |
2021-02-17 |
Glaxosmithkline Ip Dev Ltd |
PURINE CYCLIC DINUCLEOTIDES USED AS STING MODULATORS
|
CN106540260A
(en)
*
|
2015-12-09 |
2017-03-29 |
聊城市奥润生物医药科技有限公司 |
Interferon gene stimulatory protein(SP)(STING)Application of the agonist in anti-alzheimer's disease
|
CN106554416B
(en)
*
|
2015-12-09 |
2019-03-15 |
聊城市奥润生物医药科技有限公司 |
A kind of application of anti-PD-L1 Humanized monoclonal antibodies joint interferon gene stimulates the protein (STING) agonist in antitumor
|
CN106539814A
(en)
*
|
2015-12-09 |
2017-03-29 |
聊城市奥润生物医药科技有限公司 |
Interferon gene stimulatory protein(SP)(STING)Application of the agonist in the diseases such as resisting rheumatoid arthritis
|
IL259931B2
(en)
|
2015-12-16 |
2024-02-01 |
Gritstone Bio Inc |
Neoantigen identification, manufacture, and use
|
WO2017106740A1
(en)
*
|
2015-12-16 |
2017-06-22 |
Aduro Biotech, Inc. |
Methods for identifying inhibitors of "stimulator of interferon gene"-dependent interferon production
|
CN109451740B
(en)
|
2016-01-11 |
2022-09-02 |
先天肿瘤免疫公司 |
Cyclic dinucleotides for the treatment of disorders associated with STING activity, such as cancer
|
JP2019511483A
(en)
*
|
2016-03-02 |
2019-04-25 |
ザ ボード オブ リージェンツ オブ ザ ユニバーシティー オブ テキサス システム |
STING activated nanovaccine for immunotherapy
|
IL280430B2
(en)
|
2016-03-18 |
2023-11-01 |
Univ Texas |
Cyclic di-nucleotide compounds and methods of use
|
CN106539757A
(en)
*
|
2016-03-20 |
2017-03-29 |
聊城市奥润生物医药科技有限公司 |
Application of the ring dinucleotide cGAMP- liposomees in antitumor
|
CR20200045A
(en)
|
2016-04-07 |
2020-03-11 |
Glaxosmithkline Ip Dev Ltd |
Heterocyclic amides useful as protein modulators
|
EP3440072B1
(en)
|
2016-04-07 |
2020-01-29 |
GlaxoSmithKline Intellectual Property Development Ltd |
Heterocyclic amides useful as protein modulators
|
WO2017186711A1
(en)
|
2016-04-25 |
2017-11-02 |
Invivogen |
Novel complexes of immunostimulatory compounds, and uses thereof
|
US10696985B1
(en)
|
2016-06-06 |
2020-06-30 |
Vanderbilt University |
Reversibly crosslinked endosomolytic polymer vesicles for cytosolic drug delivery
|
WO2018009466A1
(en)
|
2016-07-05 |
2018-01-11 |
Aduro Biotech, Inc. |
Locked nucleic acid cyclic dinucleotide compounds and uses thereof
|
EP3481402A4
(en)
*
|
2016-07-06 |
2020-01-22 |
Sperovie Biosciences, Inc. |
Compounds, compositions, and methods for the treatment of disease
|
US10300145B2
(en)
|
2016-07-15 |
2019-05-28 |
Massachusetts Institute Of Technology |
Synthetic nanoparticles for delivery of immunomodulatory compounds
|
DE102016113714A1
(en)
|
2016-07-26 |
2018-02-01 |
Rosa Karl |
Transfection procedure with non-viral gene delivery systems
|
NL2017267B1
(en)
|
2016-07-29 |
2018-02-01 |
Aduro Biotech Holdings Europe B V |
Anti-pd-1 antibodies
|
NL2017270B1
(en)
|
2016-08-02 |
2018-02-09 |
Aduro Biotech Holdings Europe B V |
New anti-hCTLA-4 antibodies
|
EP3506884B1
(en)
|
2016-08-30 |
2021-05-05 |
Dana-Farber Cancer Institute, Inc. |
Drug delivery compositions and uses thereof
|
WO2018053508A1
(en)
*
|
2016-09-19 |
2018-03-22 |
The University Of North Carolina At Chapel Hill |
Methods and compositions for inducing an immune response
|
US10537590B2
(en)
|
2016-09-30 |
2020-01-21 |
Boehringer Ingelheim International Gmbh |
Cyclic dinucleotide compounds
|
RS62410B1
(en)
|
2016-10-04 |
2021-10-29 |
Merck Sharp & Dohme |
Benzo[b]thiophene compounds as sting agonists
|
US10266558B2
(en)
*
|
2016-10-07 |
2019-04-23 |
Alexandre Vasilievich Ivachtchenko |
Macroheterocyclic nucleoside derivatives and their analogues, production and use thereof
|
US11001605B2
(en)
|
2016-10-07 |
2021-05-11 |
Biolog Life Science Institute Gmbh & Co. Kg |
Cyclic dinucleotides containing benzimidazole, method for the production of same, and use of same to activate stimulator of interferon genes (sting)-dependent signaling pathways
|
JOP20170192A1
(en)
*
|
2016-12-01 |
2019-01-30 |
Takeda Pharmaceuticals Co |
Cyclic dinucleotide
|
WO2018119117A1
(en)
*
|
2016-12-22 |
2018-06-28 |
The Regents Of The University Of California |
Methods of producing cyclic dinucleotides
|
JP2018131427A
(en)
*
|
2017-02-17 |
2018-08-23 |
国立研究開発法人理化学研究所 |
Technology for controlling immune cells
|
US20200055883A1
(en)
*
|
2017-02-17 |
2020-02-20 |
Eisai R&D Management Co., Ltd. |
Cyclic di-nucleotides derivative for the treatment of cancer
|
CA3053568A1
(en)
|
2017-02-21 |
2018-08-30 |
Board Of Regents, The University Of Texas System |
Cyclic dinucleotides as agonists of stimulator of interferon gene dependent signalling
|
CN106928298B
(en)
*
|
2017-03-13 |
2021-10-22 |
杭州星鳌生物科技有限公司 |
Structural composition of cyclic dinucleotide cGAMP derivative, preparation method and application of cyclic dinucleotide cGAMP derivative in tumor resistance
|
JOP20190218A1
(en)
|
2017-03-22 |
2019-09-22 |
Boehringer Ingelheim Int |
Modified cyclic dinucleotide compounds
|
US10851164B2
(en)
|
2017-04-13 |
2020-12-01 |
Aduro Biotech Holdings, Europe B.V. |
Anti-SIRPα antibodies
|
MX2019012295A
(en)
|
2017-04-14 |
2020-02-07 |
Tollnine Inc |
Immunomodulating polynucleotides, antibody conjugates thereof, and methods of their use.
|
AR113224A1
(en)
|
2017-04-28 |
2020-02-19 |
Novartis Ag |
ANTIBODY CONJUGATES INCLUDING A STING AGONIST
|
UY37695A
(en)
|
2017-04-28 |
2018-11-30 |
Novartis Ag |
BIS 2’-5’-RR- (3’F-A) (3’F-A) CYCLE DINUCLEOTIDE COMPOUND AND USES OF THE SAME
|
US11466047B2
(en)
|
2017-05-12 |
2022-10-11 |
Merck Sharp & Dohme Llc |
Cyclic di-nucleotide compounds as sting agonists
|
US11969499B2
(en)
|
2017-06-16 |
2024-04-30 |
William Marsh Rice University |
Hydrogel delivery of sting immunotherapy for treatment cancer
|
AU2018311965A1
(en)
|
2017-08-04 |
2020-02-13 |
Merck Sharp & Dohme Llc |
Combinations of PD-1 antagonists and benzo[b]thiophene sting antagonists for cancer treatment
|
MA49772A
(en)
|
2017-08-04 |
2021-04-21 |
Merck Sharp & Dohme |
STING THIOPHENE BENZO [B] AGONISTS FOR CANCER TREATMENT
|
WO2019043634A2
(en)
|
2017-08-30 |
2019-03-07 |
Beijing Xuanyi Pharmasciences Co., Ltd. |
Cyclic di-nucleotides as stimulator of interferon genes modulators
|
JP7270608B2
(en)
|
2017-08-31 |
2023-05-10 |
エフ-スター・セラピューティクス・インコーポレイテッド |
Compounds, compositions, and methods of treating disease
|
US11707531B2
(en)
|
2017-09-11 |
2023-07-25 |
F-star Therapeutics, Inc. |
Compounds, compositions, and methods for the treatment of disease
|
US11584774B2
(en)
|
2017-09-11 |
2023-02-21 |
F-star Therapeutics, Inc. |
Compounds, compositions, and methods for the treatment of disease
|
MX2020002901A
(en)
|
2017-09-19 |
2020-07-22 |
Massachusetts Inst Technology |
Compositions for chimeric antigen receptor t cell therapy and uses thereof.
|
AU2018344902B2
(en)
|
2017-10-05 |
2021-06-03 |
Glaxosmithkline Intellectual Property Development Limited |
Modulators of stimulator of interferon genes (STING) useful in treating HIV
|
WO2019069270A1
(en)
|
2017-10-05 |
2019-04-11 |
Glaxosmithkline Intellectual Property Development Limited |
Modulators of stimulator of interferon genes (sting)
|
AU2018348165A1
(en)
|
2017-10-10 |
2020-05-21 |
Gritstone Bio, Inc. |
Neoantigen identification using hotspots
|
US11542293B2
(en)
|
2017-11-10 |
2023-01-03 |
Takeda Pharmaceutical Company Limited |
Sting modulator compounds, and methods of making and using
|
WO2019099578A1
(en)
|
2017-11-14 |
2019-05-23 |
Chidren's Medical Center Corporation |
Use of imidazopyrimidine for modulating human immune response
|
WO2019099564A1
(en)
|
2017-11-14 |
2019-05-23 |
Children's Medical Center Corporation |
Novel imidazopyrimidine compounds and uses thereof
|
KR20200090855A
(en)
|
2017-11-22 |
2020-07-29 |
그릿스톤 온콜로지, 인코포레이티드 |
Reduced presentation of conjugated epitopes for new antigens
|
CA3084582A1
(en)
|
2017-12-20 |
2019-06-27 |
Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. |
2'3' cyclic dinucleotides with phosphonate bond activating the sting adaptor protein
|
WO2019123340A1
(en)
|
2017-12-20 |
2019-06-27 |
Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. |
3'3' cyclic dinucleotides with phosphonate bond activating the sting adaptor protein
|
EP3727401A4
(en)
|
2017-12-20 |
2022-04-06 |
Merck Sharp & Dohme Corp. |
Cyclic di-nucleotide compounds as sting agonists
|
WO2019161171A1
(en)
*
|
2018-02-16 |
2019-08-22 |
Sperovie Biosciences, Inc. |
Nanoparticle formulations of sting agonists
|
MX2020009796A
(en)
|
2018-03-23 |
2021-01-15 |
Codiak Biosciences Inc |
Extracellular vesicles comprising sting-agonist.
|
CN111989338A
(en)
|
2018-03-27 |
2020-11-24 |
勃林格殷格翰国际有限公司 |
Modified cyclic dinucleotide compounds
|
EP3774834A1
(en)
|
2018-03-27 |
2021-02-17 |
Boehringer Ingelheim International GmbH |
Cyclic dinucleotide compounds containing 2-aza-hypoxanthine or 6h-pytazolo[1,5-d][1,2,4]triazin-7-one as sting agonists
|
CA3095646A1
(en)
|
2018-04-03 |
2019-10-10 |
Merck Sharp & Dohme Corp. |
Benzothiophenes and related compounds as sting agonists
|
WO2019195063A1
(en)
|
2018-04-03 |
2019-10-10 |
Merck Sharp & Dohme Corp. |
Aza-benzothiophene compounds as sting agonists
|
US11874276B2
(en)
|
2018-04-05 |
2024-01-16 |
Dana-Farber Cancer Institute, Inc. |
STING levels as a biomarker for cancer immunotherapy
|
TW202005654A
(en)
|
2018-04-06 |
2020-02-01 |
捷克科學院有機化學與生物化學研究所 |
2'2'-cyclic dinucleotides
|
TWI818007B
(en)
|
2018-04-06 |
2023-10-11 |
捷克科學院有機化學與生物化學研究所 |
2'3'-cyclic dinucleotides
|
JP7296398B2
(en)
|
2018-04-06 |
2023-06-22 |
インスティチュート オブ オーガニック ケミストリー アンド バイオケミストリー エーエスシーアール,ヴイ.ヴイ.アイ. |
3'3'-cyclic dinucleotide
|
US20190359645A1
(en)
|
2018-05-03 |
2019-11-28 |
Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. |
2'3'-cyclic dinucleotides comprising carbocyclic nucleotide
|
GB201807924D0
(en)
|
2018-05-16 |
2018-06-27 |
Ctxt Pty Ltd |
Compounds
|
WO2019227007A1
(en)
|
2018-05-25 |
2019-11-28 |
Incyte Corporation |
Tricyclic heterocyclic compounds as sting activators
|
BR112020024605A2
(en)
|
2018-06-01 |
2021-04-06 |
Eisai R&D Management Co., Ltd. |
METHODS FOR TREATING BLADDER CANCER
|
US11008344B2
(en)
|
2018-07-31 |
2021-05-18 |
Incyte Corporation |
Tricyclic heteroaryl compounds as STING activators
|
US10875872B2
(en)
|
2018-07-31 |
2020-12-29 |
Incyte Corporation |
Heteroaryl amide compounds as sting activators
|
US11564993B2
(en)
|
2018-08-03 |
2023-01-31 |
The University Of Tokyo |
Intranasal vaccine that induces cellular immunity
|
CN112041325B
(en)
|
2018-08-16 |
2023-10-24 |
卫材R&D管理有限公司 |
Salts of compounds and crystals thereof
|
AU2019337051B2
(en)
|
2018-09-06 |
2023-11-23 |
Daiichi Sankyo Company, Limited |
Novel cyclic dinucleotide derivative and antibody-drug conjugate thereof
|
JP2021535930A
(en)
*
|
2018-09-17 |
2021-12-23 |
キュラティス インコーポレイティッド |
Antigenic enhancer and vaccine composition comprising a STING agonist
|
CA3113425A1
(en)
|
2018-09-21 |
2020-03-26 |
Shanghai De Novo Pharmatech Co., Ltd. |
Cyclic dinucleotide analogue, pharmaceutical composition thereof, and application
|
US11110106B2
(en)
|
2018-10-29 |
2021-09-07 |
Venenum Biodesign, LLC |
Sting agonists for treating bladder cancer and solid tumors
|
US11161864B2
(en)
|
2018-10-29 |
2021-11-02 |
Venenum Biodesign, LLC |
Sting agonists
|
WO2020092633A1
(en)
|
2018-10-30 |
2020-05-07 |
Vanderbilt University |
Graft copolymers, methods of forming graft copolymers, and methods of use thereof
|
JP2022509929A
(en)
|
2018-10-31 |
2022-01-25 |
ノバルティス アーゲー |
DC-SIGN antibody conjugate containing STING agonist
|
US11596692B1
(en)
|
2018-11-21 |
2023-03-07 |
Incyte Corporation |
PD-L1/STING conjugates and methods of use
|
JP7224688B2
(en)
*
|
2019-01-10 |
2023-02-20 |
南▲開▼大学 |
Cyclic dinucleotide prodrug molecules, methods of making and uses thereof
|
EP3935065A1
(en)
|
2019-03-07 |
2022-01-12 |
Institute of Organic Chemistry and Biochemistry ASCR, V.V.I. |
3'3'-cyclic dinucleotide analogue comprising a cyclopentanyl modified nucleotide as sting modulator
|
EP3934757B1
(en)
|
2019-03-07 |
2023-02-22 |
Institute of Organic Chemistry and Biochemistry ASCR, V.V.I. |
2'3'-cyclic dinucleotides and prodrugs thereof
|
US20220143061A1
(en)
|
2019-03-07 |
2022-05-12 |
Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. |
3'3'-cyclic dinucleotides and prodrugs thereof
|
WO2020191369A1
(en)
|
2019-03-21 |
2020-09-24 |
Codiak Biosciences, Inc. |
Process for preparing extracellular vesicles
|
CN113747925A
(en)
|
2019-03-21 |
2021-12-03 |
科迪亚克生物科学公司 |
Extracellular vesicle conjugates and uses thereof
|
US20220168415A1
(en)
|
2019-03-21 |
2022-06-02 |
Codiak Biosciences, Inc. |
Extracellular vesicles for vaccine delivery
|
US20220177465A1
(en)
|
2019-04-04 |
2022-06-09 |
Merck Sharp & Dohme Corp. |
Inhibitors of histone deacetylase-3 useful for the treatment of cancer, inflammation, neurodegeneration diseases and diabetes
|
TW202104214A
(en)
|
2019-04-05 |
2021-02-01 |
英商葛蘭素史密斯克藍智慧財產發展有限公司 |
Chemical compounds
|
EP3962493A2
(en)
|
2019-05-03 |
2022-03-09 |
Flagship Pioneering Innovations V, Inc. |
Methods of modulating immune activity/level of irf or sting or of treating cancer, comprising the administration of a sting modulator and/or purinergic receptor modulator or postcellular signaling factor
|
US11787833B2
(en)
|
2019-05-09 |
2023-10-17 |
Aligos Therapeutics, Inc. |
Modified cyclic dinucleoside compounds as sting modulators
|
JP2022532192A
(en)
|
2019-05-10 |
2022-07-13 |
武田薬品工業株式会社 |
Antibody drug conjugate
|
US20230181758A1
(en)
|
2019-07-03 |
2023-06-15 |
Codiak Biosciences, Inc. |
Extracellular vesicles targeting dendritic cells and uses thereof
|
WO2021003445A1
(en)
|
2019-07-03 |
2021-01-07 |
Codiak Biosciences, Inc. |
Extracellular vesicles targeting t cells and uses thereof
|
GB201910304D0
(en)
|
2019-07-18 |
2019-09-04 |
Ctxt Pty Ltd |
Compounds
|
GB201910305D0
(en)
|
2019-07-18 |
2019-09-04 |
Ctxt Pty Ltd |
Compounds
|
JP2022543086A
(en)
|
2019-08-02 |
2022-10-07 |
メルサナ セラピューティクス インコーポレイテッド |
Bis-[N-((5-carbamoyl)-1H-benzo[d]imidazol-2-yl)-pyrazole-5-carboxamide] derivatives as STING (interferon gene stimulator) agonists for the treatment of cancer and related Compound
|
MX2022001732A
(en)
|
2019-08-12 |
2022-05-06 |
Purinomia Biotech Inc |
Methods and compositions for promoting and potentiating t-cell mediated immune responses through adcc targeting of cd39 expressing cells.
|
WO2021041532A1
(en)
|
2019-08-26 |
2021-03-04 |
Dana-Farber Cancer Institute, Inc. |
Use of heparin to promote type 1 interferon signaling
|
EP3785719A1
(en)
*
|
2019-08-28 |
2021-03-03 |
Helmholtz-Zentrum für Infektionsforschung GmbH |
New use of cyclic dinucleotides
|
WO2021062058A1
(en)
|
2019-09-25 |
2021-04-01 |
Codiak Biosciences, Inc. |
Sting agonist comprising exosomes for treating neuroimmunological disorders
|
EP4034276A1
(en)
|
2019-09-25 |
2022-08-03 |
Codiak BioSciences, Inc. |
Methods of producing extracellular vesicles
|
AU2020355240A1
(en)
|
2019-09-25 |
2022-04-21 |
Lonza Sales Ag |
Extracellular vesicle compositions
|
KR20220094221A
(en)
|
2019-09-25 |
2022-07-05 |
코디악 바이오사이언시즈, 인크. |
Exosomes with STING agonists in combination with IL-12 displaying exosomes for the treatment of tumors
|
WO2021074695A1
(en)
|
2019-10-16 |
2021-04-22 |
Avacta Life Sciences Limited |
PD-L1 INHIBITOR - TGFβ INHIBITOR BISPECIFIC DRUG MOIETIES.
|
EP4069683A1
(en)
|
2019-12-06 |
2022-10-12 |
Mersana Therapeutics, Inc. |
Dimeric compounds as sting agonists
|
US11744874B2
(en)
|
2019-12-20 |
2023-09-05 |
Nammi Therapeutics, Inc. |
Formulated and/or co-formulated liposome compositions containing toll-like receptor (“TLR”) agonist prodrugs useful in the treatment of cancer and methods thereof
|
WO2021168274A1
(en)
|
2020-02-21 |
2021-08-26 |
Silverback Therapeutics, Inc. |
Nectin-4 antibody conjugates and uses thereof
|
MX2022010515A
(en)
|
2020-02-28 |
2022-11-14 |
Tallac Therapeutics Inc |
Transglutaminase-mediated conjugation.
|
IL296124A
(en)
|
2020-03-06 |
2022-11-01 |
Daiichi Sankyo Co Ltd |
Antibody-drug conjugate including novel cyclic dinucleotide derivative
|
WO2021184017A1
(en)
|
2020-03-13 |
2021-09-16 |
Codiak Biosciences, Inc. |
Extracellular vesicles for treating neurological disorders
|
JP2023518414A
(en)
|
2020-03-20 |
2023-05-01 |
コディアック バイオサイエンシーズ, インコーポレイテッド |
Extracellular vesicles for therapy
|
EP4134098A4
(en)
|
2020-04-10 |
2024-05-15 |
Ono Pharmaceutical Co |
Method of cancer therapy
|
WO2021216572A1
(en)
|
2020-04-20 |
2021-10-28 |
Massachusetts Institute Of Technology |
Lipid compositions for delivery of sting agonist compounds and uses thereof
|
WO2021221783A1
(en)
|
2020-05-01 |
2021-11-04 |
Massachusetts Institute Of Technology |
Methods for identifying chimeric antigen receptor-targeting ligands and uses thereof
|
WO2021221782A1
(en)
|
2020-05-01 |
2021-11-04 |
Massachusetts Institute Of Technology |
Chimeric antigen receptor-targeting ligands and uses thereof
|
IL298019A
(en)
|
2020-05-13 |
2023-01-01 |
Massachusetts Inst Technology |
Compositions of polymeric microdevices and their use in cancer immunotherapy
|
WO2021237100A1
(en)
|
2020-05-21 |
2021-11-25 |
Codiak Biosciences, Inc. |
Methods of targeting extracellular vesicles to lung
|
AU2021300362A1
(en)
|
2020-07-01 |
2023-02-23 |
ARS Pharmaceuticals, Inc. |
Anti-ASGR1 antibody conjugates and uses thereof
|
JPWO2022050300A1
(en)
|
2020-09-02 |
2022-03-10 |
|
|
WO2022066928A2
(en)
|
2020-09-23 |
2022-03-31 |
Codiak Biosciences, Inc. |
Process for preparing extracellular vesicles
|
WO2022066883A1
(en)
|
2020-09-23 |
2022-03-31 |
Codiak Biosciences, Inc. |
Extracellular vesicles comprising kras antigens and uses thereof
|
US20240082389A1
(en)
|
2020-09-23 |
2024-03-14 |
Lonza Sales Ag |
Methods of producing extracellular vesicles
|
WO2022066934A2
(en)
|
2020-09-23 |
2022-03-31 |
Codiak Biosciences, Inc. |
Process for preparing extracellular vesicles
|
EP4228681A1
(en)
|
2020-10-14 |
2023-08-23 |
Boehringer Ingelheim International GmbH |
Combination of a sting agonist and a complex comprising a cell penetrating peptide, a cargo and a tlr peptide agonist
|
US20240059729A1
(en)
*
|
2020-10-20 |
2024-02-22 |
Tyligand Bioscience (Shanghai) Limited |
Multifunctional cyclic dinucleotide and use thereof
|
MX2023005381A
(en)
|
2020-11-09 |
2023-05-23 |
Takeda Pharmaceuticals Co |
Antibody drug conjugates.
|
CN116981479A
(en)
|
2020-12-17 |
2023-10-31 |
塔夫茨大学信托人 |
FAP-activated radiation therapy diagnostic method and use relating thereto
|
EP4032545A1
(en)
*
|
2021-01-26 |
2022-07-27 |
Medizinische Hochschule Hannover |
Immunogenic composition and vaccine containing chlamydia ssp. surface antigens and its use
|
EP4326321A1
(en)
|
2021-04-20 |
2024-02-28 |
Institut Curie |
Compositions and methods for use in immunotherapy
|
JP2024514707A
(en)
|
2021-04-20 |
2024-04-02 |
アンスティテュ・クリー |
Compositions and methods for use in immunotherapy
|
WO2022234003A1
(en)
|
2021-05-07 |
2022-11-10 |
Avacta Life Sciences Limited |
Cd33 binding polypeptides with stefin a protein
|
WO2023056468A1
(en)
|
2021-09-30 |
2023-04-06 |
Codiak Biosciences, Inc. |
Extracellular vesicle comprising cholesterol tagged sting-agonist
|
TW202334196A
(en)
|
2021-10-07 |
2023-09-01 |
英商阿法克塔生命科學有限公司 |
Pd-l1 binding polypeptides
|
US20230414763A1
(en)
|
2022-03-04 |
2023-12-28 |
Massachusetts Institute Of Technology |
Transmucosal amphiphile-protein conjugate vaccine
|
WO2023218243A1
(en)
|
2022-05-12 |
2023-11-16 |
Avacta Life Sciences Limited |
Lag-3/pd-l1 binding fusion proteins
|
WO2024036275A1
(en)
*
|
2022-08-10 |
2024-02-15 |
Aldevron Llc |
Methods for producing cyclic dinucleotides
|